Trial intelligence / Profile preview

IMPACT: Vasopressor Impact on Brain Circulation During Anesthesia

NCT06083948Phase 3Recruiting

Sponsor
Aarhus University
Start
Dec 2023
Primary completion
Dec 2027
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of norepinephrine in hypotension (2 arms), sponsored by Aarhus University. Primary endpoint: Cerebral blood flow at 3 hours. Started Dec 2023; status: recruiting.

02

Drugs

norepinephrine
03

Conditions

hypotension

Beyond the preview

Go deeper on NCT06083948.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06083948.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call